Chronic HBV was associated with increased risk for adverse COVID-19 outcomes, but the risk was lower among coinfected patients vaccinated against COVID-19.

Andrew Nixon, spokesman for Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., announced on ...

The initiative aims to improve infectious disease management. T Cell Diagnostics Pte. Ltd. (TCD) has licensed an intellectual ...

NEW YORK – Uppsala University spinout Readily Diagnostics is using technology built off 30 years of research as the basis of a point-of-care, instrument-free test that would detect and differentiate ...

HTLV-2), Hepatitis B virus (HBV) Hepatitis C virus (HCV) and PBMCs from Covid-19 (SARS-CoV-2) patients. We are happy to provide help and advice on biosafety, sample preparation, experimental, and ...

Functional cure, defined as durable hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA titers below the ...

Dynavax is kicking off May’s Hepatitis Awareness Month with a new push to improve education around hepatitis B and the ...

Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...